New Mexico Educational Retirement Board Ligand Pharmaceuticals Inc Transaction History

New Mexico Educational Retirement Board

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 19, 2021	SELL	$102.33 - $144.73 $347,922 - $492,081	-3,400 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$113.03 - $155.64 $67,818 - $93,383	600 Added 21.43%	3,400 $446,000
Q4 2020 Feb 02, 2021	SELL	$80.55 - $106.05 $40,275 - $53,025	-500 Reduced 15.15%	2,800 $278,000
Q3 2020 Oct 28, 2020	SELL	$89.56 - $126.72 $17,912 - $25,344	-200 Reduced 5.71%	3,300 $315,000
Q3 2020 Oct 27, 2020	SELL	$89.56 - $126.72 $35,824 - $50,688	-400 Reduced 10.26%	3,500 $348,000
Q1 2020 Jun 11, 2020	BUY	$63.37 - $107.88 $25,348 - $43,152	400 Added 11.43%	3,900 $284,000
Q2 2019 Aug 06, 2019	SELL	$107.38 - $129.34 $85,904 - $103,472	-800 Reduced 18.6%	3,500 $400,000
Q4 2018 Jan 28, 2019	BUY	$128.36 - $272.13 $551,948 - $1.17 Million	4,300 New	4,300 $584,000

255

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.79B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of New Mexico Educational Retirement Board, based on Form 13F filings with the SEC.

Stay updated on New Mexico Educational Retirement Board with notifications on news.